Dupont De Nemours Inc (DD)
DuPont Schedules Fourth Quarter 2025 Earnings Conference Call
Ensysce Biosciences Inc. (ENSC)
Ensysce Biosciences Expands Global Opioid Patent Portfolio
PAVmed Inc (PAVMZ)
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®
PAVmed Inc (PAVM)
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®
Genmab A/S (GNMSF)
Curaleaf Hldgs Inc. (CURLF)
Curaleaf Celebrates Launch of Adult-Use Sales in Maine at Bangor Dispensary
Agenus Inc. (AGEN)
Agenus Inc. - Agenus Expands Medical Affairs Infrastructure to Support Increasing Physician Requests for Authorized Access to Botensilimab Plus Balstilimab
Brainsway Ltd (BWAY)
BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™
Venus Concept Inc (VERO)
Venus Concept Announces Intention to Voluntary Delist from Nasdaq and Deregister with SEC
Bausch Health Companies Inc (BHC)
Bausch Health Notification
Exicure Inc. (XCUR)
Exicure, Inc. - Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings
Quidel Corporation (QDEL)
QuidelOrtho Corporation - QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results
Lisata Therapeutics Inc (LSTA)
Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer
Exicure Inc. (XCUR)
Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings
Quidel Corporation (QDEL)
QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results